Dataset Information

Brain tumor magnetic resonance images classification based machine learning paradigms.

ABSTRACT:

Introduction

Cancer of the nervous system is one of the most common types of cancer in the world and mostly due to presence of a tumour in the brain. The symptoms and severity of the brain tumour depend on its location. The tumour within the brain may develop from nerves, dura (meningioma), pituitary gland (pituitary adenoma), or from the brain tissue itself (glioma).

Material and methods

In this study we proposed a feature engineering approach for classification magnetic resonance imaging (MRI) of 3 kinds of most common brain tumour, i.e. glioma, meningioma, pituitary, and no-tumour. Here 5 machine learning classifiers were used, i.e. support vector machine, K-nearest neighbour (KNN), Naive Bayes, Decision Tree, and Ensemble classifier with their paradigms.

Results

The handcrafted features such as histogram of oriented gradients, local binary pattern features, and grey level co-occurrence matrix are extracted from the MRI, and the feature fusion technique is adopted to enhance the dimension of feature vector. The Fine KNN outperforms among the classifiers for recognition of 4 kinds of MRI: glioma, meningioma, pituitary, and no tumour, and achieved 91.1% accuracy and 0.95 area under the curve (AUC).

Conclusions

The proposed method, i.e. Fine KNN, achieved 91.1% accuracy and 0.96 AUC. Furthermore, this model has the possibility to integrate in low-end devices unlike deep learning, which required a complex system.

SUBMITTER: Pattanaik BB

PROVIDER: S-EPMC9933351 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Brain tumor magnetic resonance images classification based machine learning paradigms.

Pattanaik Baby Barnali BB Anitha Komma K Rathore Shanti S Biswas Preesat P Sethy Prabira Kumar PK Behera Santi Kumari SK

Contemporary oncology (Poznan, Poland) 20221230 4

<h4>Introduction</h4>Cancer of the nervous system is one of the most common types of cancer in the world and mostly due to presence of a tumour in the brain. The symptoms and severity of the brain tumour depend on its location. The tumour within the brain may develop from nerves, dura (meningioma), pituitary gland (pituitary adenoma), or from the brain tissue itself (glioma).<h4>Material and methods</h4>In this study we proposed a feature engineering approach for classification magnetic resonanc ...[more]

PMID: 36816391

Similar Datasets

Project description:Purpose: The construction and validation of a radiomics nomogram based on machine learning using magnetic resonance image (MRI) for predicting the efficacy of neoadjuvant chemotherapy (NACT) in patients with breast cancer (BCa). Methods: This retrospective investigation consisted of 158 patients who were diagnosed with BCa and underwent MRI before NACT, of which 33 patients experienced pathological complete response (pCR) by the postoperative pathological examination. The patients with BCa were divided into the training set (n = 110) and test set (n = 48) randomly. The features were selected by the maximum relevance minimum redundancy (mRMR) and absolute shrinkage and selection operator (LASSO) algorithm in the training set. In return, the radiomics signature was established using machine learning. The predictive score of each patient was calculated using the radiomics signature formula. Finally, the predictive scores and clinical factors were used to perform the multivariate logistic regression and construct the nomogram. Receiver operating characteristics (ROC) analyses were used to assess and validate the diagnostic accuracy of the nomogram in the test set. Lastly, the usefulness of the nomogram was confirmed via decision curve analysis (DCA). Results: The radiomics signature was well-discriminated in the training set [AUC 0.835, specificity 71.32%, and sensitivity 82.61%], and test set (AUC 0.834, specificity 73.21%, and sensitivity 80%). Containing the radiomics signature and hormone status, the radiomics nomogram showed good calibration and discrimination in the training set [AUC 0.888, specificity 79.31%, and sensitivity 86.96%] and test set (AUC 0.879, specificity 82.19%, and sensitivity 83.57%). The decision curve indicated the clinical usefulness of our nomogram. Conclusion: Our radiomics nomogram showed good discrimination in patients with BCa who experience pCR after NACT. The model may aid physicians in predicting how specific patients may respond to BCa treatments in the future.

Project description:ObjectivesThis study aimed to determine whether texture analysis (TA) and machine learning-based classifications can be applied in differential diagnosis of cardiac amyloidosis (CA) and hypertrophic cardiomyopathy (HCM) using non-contrast cine cardiac magnetic resonance (CMR) images.MethodsIn this institutional review board-approved study, we consecutively enrolled 167 patients with CA (n = 85), HCM (n = 82), and 84 patients with normal CMR served as controls. All cases were randomized into training [119 patients (70%)] and validation [48 patients (30%)] groups. A total of 275 texture features were extracted from cine images. Based on regression analysis with the least absolute shrinkage and selection operator (LASSO), nine machine learning models were established and their diagnostic performance determined.ResultsNineteen radiomics texture features derived from cine images were used to differentiate CA and HCM. In the validation cohort, the support vector machine (SVM), which had an accuracy of 0.85, showed the best performance (MCC = 0.637). Gray level non-uniformity (GLevNonU) was the single most effective feature. The combined model of radiomics texture features and conventional MR metrics had superior discriminatory performance (AUC = 0.89) over conventional MR metrics model (AUC = 0.79). Moreover, results showed that GLevNonU levels in HCM patients were significantly higher compared with levels in CA patients and control groups (P < 0.001). A cut-off of GLevNonU ≥ 25 was shown to differentiate between CA and HCM patients, with an area under the curve (AUC) of 0.86 (CI:0.804-0.920). Multiple comparisons tests showed that GLevNonU was significantly greater in LGE+, relative to LGE-patient groups (CA+ vs. CA- and HCM+ vs. HCM-, P = 0.01, 0.001, respectively).ConclusionMachine learning-based classifiers can accurately differentiate between CA and HCM on non-contrast cine images. The radiomics-MR combined model can be used to improve the discriminatory performance. TA may be used to assess myocardial microstructure changes that occur during different stages of cardiomyopathies.

Project description:ImportanceDeep learning may be able to use patient magnetic resonance imaging (MRI) data to aid in brain tumor classification and diagnosis.ObjectiveTo develop and clinically validate a deep learning system for automated identification and classification of 18 types of brain tumors from patient MRI data.Design, setting, and participantsThis diagnostic study was conducted using MRI data collected between 2000 and 2019 from 37 871 patients. A deep learning system for segmentation and classification of 18 types of intracranial tumors based on T1- and T2-weighted images and T2 contrast MRI sequences was developed and tested. The diagnostic accuracy of the system was tested using 1 internal and 3 external independent data sets. The clinical value of the system was assessed by comparing the tumor diagnostic accuracy of neuroradiologists with vs without assistance of the proposed system using a separate internal test data set. Data were analyzed from March 2019 through February 2020.Main outcomes and measuresChanges in neuroradiologist clinical diagnostic accuracy in brain MRI scans with vs without the deep learning system were evaluated.ResultsA deep learning system was trained among 37 871 patients (mean [SD] age, 41.6 [11.4] years; 18 519 women [48.9%]). It achieved a mean area under the receiver operating characteristic curve of 0.92 (95% CI, 0.84-0.99) on 1339 patients from 4 centers' data sets in diagnosis and classification of 18 types of tumors. Higher outcomes were found compared with neuroradiologists for accuracy and sensitivity and similar outcomes for specificity (for 300 patients in the Tiantan Hospital test data set: accuracy, 73.3% [95% CI, 67.7%-77.7%] vs 60.9% [95% CI, 46.8%-75.1%]; sensitivity, 88.9% [95% CI, 85.3%-92.4%] vs 53.4% [95% CI, 41.8%-64.9%]; and specificity, 96.3% [95% CI, 94.2%-98.4%] vs 97.9%; [95% CI, 97.3%-98.5%]). With the assistance of the deep learning system, the mean accuracy of neuroradiologists among 1166 patients increased by 12.0 percentage points, from 63.5% (95% CI, 60.7%-66.2%) without assistance to 75.5% (95% CI, 73.0%-77.9%) with assistance.Conclusions and relevanceThese findings suggest that deep learning system-based automated diagnosis may be associated with improved classification and diagnosis of intracranial tumors from MRI data among neuroradiologists.

Dataset Information

Brain tumor magnetic resonance images classification based machine learning paradigms.

Introduction

Material and methods

Results

Conclusions

Publications

Brain tumor magnetic resonance images classification based machine learning paradigms.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets